Table of Contents
This BCC Research report determines the status of current and emerging biochip technologies and products and assess their worldwide growth potential over a five-year period from 2015 to 2020. The study is particularly focused on characterizing the biochip markets by type (DNA microarray, protein microarray, emerging microarray, lab-on-a-chip); by function (gene expression, genotyping, micro-RNA, epigenetic, sequence capture); and by end user (R&D tools, drug discovery, and development, diagnostics, sequencing, applied).
Use this report to:
Receive information about major biochip platforms, including DNA and protein microarrays, tissue/cell and glycomics microarrays, LOAC products and NGS.
Gain an insight into technology status and market driving forces.
Analyze the applications for biochips-based diagnostics.
The global market for biochip products reached nearly $3.9 billion in 2014. This market is projected to grow from $4.7 billion in 2015 to $18.4 billion in 2020, representing a compound annual growth rate (CAGR) of 31.6% between 2015 and 2020.
The clinical industry of this market will grow from $2.3 billion in 2015 to $14.7 billion in 2020 at a CAGR of 44.5%.
Drug discovery and development industry of this market will grow from nearly $1.3 billion in 2015 to $2.1 billion in 2020 at a CAGR of 11.2%.
STUDY GOALS AND OBJECTIVES
BCC Research’s main goal for this study is to determine the status of current and emerging biochip technologies and products, in order to assess their worldwide growth potential over a five-year period from 2015 to 2020. In particular, this report will attempt to characterize the biochip markets by type (DNA microarray, protein
microarray, emerging microarray, lab-on-a-chip); by function (gene expression, genotyping, micro-RNA, epigenetic, sequence capture); and by end user.
A particular focus of this study is the market for biochip-based diagnostics products, which highlights a major future market segment for biochips. Our key objective is to present a comprehensive discussion of the main commercial biochip technologies and the current and future commercial potential for each of the key market segments.
REASONS FOR DOING THE STUDY
In 2011, BCC Research examined the biochips industry, which has since experienced numerous industry alliances and acquisitions that have changed the competitive dynamics of the sector. In addition, emerging markets for biochips in diagnostics are beginning to gain traction. These changing industry and market dynamics necessitate a re-examination of the total industry.
The main biochips platforms are also undergoing a transition. DNA microarrays are being influenced by next-generation sequencing (NGS) applications, as well as exciting new applications in rapid DNA analysis and diagnostics. Protein microarrays continue to make progress in the market, as well as emerging microarray classes (tissue/cell and glycomics).
Lab-on-a-chip (LOAC) applications are becoming more important in point-of-care diagnostics applications, as well as in drug discovery and development.
NGS applications continue to increase as a result of lowered costs and better informatics support.
It is important to keep up with these trends and their influence on the biochips market. This report aims to guide companies in these industries about the important trends in biochips as well as provide detailed information about the individual market segments and industry dynamics.
SCOPE AND FORMAT OF REPORT
The study scope includes the major biochip platforms, including DNA and protein microarrays, tissue/cell and glycomics microarrays, LOAC products and NGS. Each platform is analyzed to determine its market status, impact on future market segments, and forecast growth from 2015 through 2020. Technology status and market driving forces are discussed, as well as influencing market factors like industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.
In addition to the main LOAC, microarray and sequencing industries, BCC Research profiles several specialized biochip industry segments including the following: DNA analyzers, ion channel screening, digital PCR, label-free detection, nanoarray, peptide microarray, antibody microarray, antibody reagents, multiplex protein diagnostics,
circulating tumor cell, prenatal screening, point of care CD4 counting and China’s biochips industries.
Applications for biochips-based diagnostics are highlighted in this report — particularly cancer diagnostics — as well as new data about biochip substrate types.
This BCC Research report also analyzes patent data for each biochip type. The industry has grown significantly since the last report, and nearly 300 companies are profiled in our analysis.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
Use this report to: - Assess current market dynamics and estimate future demand for sample preparation in genomics, proteomics and epigenomics. - Gain insight into existing products as well as new developments ...
Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications The primary goal of this research is to analyze the current and future adoption plans ...
Global Non-alcoholic Steatohepatitis Biomarker Market: Overview Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). ...